Carlsmed, Inc. (CARL) Stock

NASDAQ: CARLHealthcare company in the health information services industry, based in Carlsbad, CA.

Carlsmed stock price chart

CARL interactive chart →

CARL stock quote & key statistics

Carlsmed earnings per share

Income →

Earnings per share

Carlsmed revenue & net income

Income →

RevenueNet income

Carlsmed annual financials

Income statement →

Carlsmed, Inc. revenue, net income and EPS by fiscal year
Fiscal year	Revenue	Net income	EPS
FY2025	$50.5M	-$29.6M	-$2.32
FY2024	$27.2M	-$24.3M	—
FY2023	$13.8M	-$18.9M	—

Fiscal year ending December 31. Source: company filings via EODHD.

About Carlsmed, Inc.

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

Carlsmed stock FAQ

What is the Carlsmed stock ticker symbol?

Carlsmed, Inc. trades on the NASDAQ under the ticker symbol CARL.

What sector and industry is Carlsmed in?

Carlsmed, Inc. is classified in the Healthcare sector, Health Information Services industry.

How many employees does Carlsmed have?

Carlsmed, Inc. has about 127 full-time employees.

What were Carlsmed's revenue and earnings last fiscal year?

Carlsmed reported revenue of $50.5M and net income of -$29.6M in fiscal 2025, with earnings per share of -$2.32. Revenue grew 85.9% from the prior year.

Is Carlsmed in the Russell 2000?

Yes. Carlsmed, Inc. (CARL) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.

When did Carlsmed go public?

Carlsmed stock began trading on July 23, 2025.